Profile Founder History Team

Profile

 

   博雅辑因成立于2015年,致力于将前沿的基因组编辑技术转化为治疗遗传病和癌症的创新疗法,以及药物研发的创造性解决方案。
      2018年,博雅辑因受到《Nature Biotechnology》报道,被列入十家被资本看好的技术密集型初创公司。
      2019年,EdiGene获评FastCompany杂志“中国最佳创新公司50”。


Founder

 

Wensheng Wei, Ph.D.

Founder of EdiGene.Principle Investigator at Peking University since 2007, Professor Wei is also Director of Peking University Genome Editing Research Center and Deputy Director of Genome Editing Chapter of the Genetics Society of China. His Group has 30+ publications in top research journals, of which over 20 are in the field of genome editing.


History

 


Team

 

EdiGene has built a strong team of talents with expertise in developing cutting-edge technologies such as genome editing, stem cells and cell therapy, and with experience in innovative drug development and management in multinational and domestic biotechnology companies. Over 40 EdiGene colleagues have advanced degrees with 17 having Ph.D. or M.D. degrees.

Generic placeholder image

CEO

魏东, 博士

Generic placeholder image

COO

司亚君

Generic placeholder image

CTO

袁鹏飞, 博士

Generic placeholder image

临床注册副总裁

李云, 医学博士

Generic placeholder image

生产质控总监

石佳, 博士

Generic placeholder image

研发总监

方日国, 博士

Contact Us


Headquarters

EdiGene Inc.

Life Science Park, 22 KeXue Yuan Road,Changping District, Beijing, P.R. China

Guangzhou Branch

EdiGene Guangzhou Inc.

Building 10, No.6, Nanjiang Second Road, Nansha District, Guangzhou, China

USA Branch

EDIGENE BIOTECHNOLOGY USA INC.

245 FIRST STREET, RIVERVIEW II, 18TH FLOORCAMBRIDGE, MA 02142 USA

Leave us a message

Introduction


Profile

Founder

History

Team
Click to follow us